How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries
We conducted research to assess hospital pharmacists’ familiarity with/interpretation of data requirements for the different regulatory approval frameworks and the impact of this on their approach to substitution in the formulary. The online questionnaire included a small molecule (acetylsalicylic a...
Main Authors: | Natalia Sofia, Stefan Mühlebach, Umberto M. Musazzi, Rani Khatib, José Manuel Martinez Sesmero, Hans-Peter Lipp, Jacqueline Surugue, Tiziana Di Francesco, Beat Flühmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/7/1010 |
Similar Items
-
Financial management for health-system pharmacists /
by: Wilson, Andrew L, et al.
Published: (2009) -
Need for Expansion of Pharmacy Education Globally for the Growing Field of Nanomedicine
by: Amy E. Barton, et al.
Published: (2022-01-01) -
Use of an Innovative Pharmaceutical Class Scoring Tool for Prioritized Annual Formulary Review
by: Holly Sheldon, et al.
Published: (2022-06-01) -
Progress in the search for blood substitutes, part 1
Preparations currently used in haemotherapy as an indicator of new drug development
by: Waldemar Grzegorzewski, et al.
Published: (2022-10-01) -
The use of special approval medicines among pediatric patients in a tertiary care hospital: A reality check
by: Shamala Balan, et al.
Published: (2022-12-01)